Medical Conditions

Retinopathy of Prematurity

The short answer

Retinopathy of prematurity (ROP) is a condition affecting the developing blood vessels of the retina in premature infants. It is most common in babies born before 31 weeks of gestation or weighing less than 1,500 grams (3.3 pounds). In mild cases, the abnormal blood vessels regress on their own. In severe cases, the abnormal vessels can cause scarring, retinal detachment, and blindness. All at-risk premature infants receive screening eye exams in the NICU, and treatment (laser therapy or anti-VEGF injections) is highly effective when needed.

By Age

What to expect by age

Screening for ROP typically begins at 4-6 weeks of age (or 31-33 weeks postmenstrual age, whichever is later). The eye exam is performed by an ophthalmologist using an indirect ophthalmoscope after dilating the baby's pupils. ROP is classified by stage (1-5), zone (location on the retina), and the presence of plus disease (dilated, tortuous blood vessels). Most mild ROP (stages 1-2) resolves without treatment.

Follow-up examinations continue until the retinal blood vessels have matured completely or until the ophthalmologist determines that the risk of ROP progression has passed. If ROP progresses to treatment-threshold disease (typically stage 3 with plus disease), treatment is performed urgently, usually within 72 hours. Treatment options include laser photocoagulation or intravitreal anti-VEGF injections.

By this age, ROP has typically resolved or been treated. However, children who had ROP (even if it resolved on its own) are at increased risk for other eye problems including myopia (nearsightedness), strabismus, amblyopia, and late retinal detachment. Regular ophthalmologic follow-up is recommended throughout childhood.

Long-term follow-up is essential for all children who had ROP. Even mild ROP increases the risk of significant refractive errors, requiring glasses from an early age. Children who had severe ROP or required treatment need more frequent monitoring for late complications such as retinal detachment, glaucoma, or cataracts. Early intervention services should be utilized if vision impairment affects development.

What Should You Do?

When to take action

Probably normal when...
  • Your premature baby had ROP screening exams that showed no ROP or only stage 1-2 ROP that resolved on its own
  • The ophthalmologist has discharged your baby from ROP screening because the retinal vessels have matured normally
  • Your child who had mild ROP has normal vision development at follow-up exams
  • Your premature baby was screened appropriately and no treatment was needed
Mention at your next visit when...
  • Your premature baby has not been screened for ROP and you want to confirm it was done or arrange it
  • Your child had ROP and you notice them squinting, sitting close to the TV, or having difficulty seeing
  • You want to discuss the long-term eye care plan for your child who had ROP
Act now when...
  • Your baby has been diagnosed with treatment-threshold ROP (stage 3 with plus disease), as treatment is needed within 72 hours to prevent retinal detachment and permanent vision loss
  • A child with a history of severe ROP suddenly develops vision changes, a white pupil, or eye pain, which could indicate late retinal detachment or other serious complications requiring emergency ophthalmologic evaluation

Sources

My Baby's Head Shape Looks Abnormal

Many babies develop temporary head shape irregularities that are completely normal. A cone-shaped head from vaginal delivery reshapes within days. Mild positional flattening (plagiocephaly) from sleeping on the back is very common and usually improves with repositioning and tummy time. However, head shape changes involving ridges, a persistently bulging fontanelle, or rapid head growth changes should be evaluated to rule out craniosynostosis.

Achondroplasia (Dwarfism) in Babies

Achondroplasia is the most common form of short-limbed dwarfism, affecting about 1 in 15,000 to 40,000 births. It is caused by a mutation in the FGFR3 gene and is usually apparent at birth with characteristic features including short limbs, a larger head, and a prominent forehead. Intelligence is normal. With monitoring for specific complications and supportive care, children with achondroplasia lead full, active, and independent lives.

Adenoid Hypertrophy and Breathing

Adenoids are lymphoid tissue located behind the nose that help fight infection in young children. When adenoids become enlarged (adenoid hypertrophy), they can block the nasal airway, causing chronic mouth breathing, snoring, nasal speech, and sleep-disordered breathing. Enlarged adenoids are most common between ages 2-7 and are a leading cause of obstructive sleep apnea in young children. Treatment ranges from watchful waiting and nasal steroids to surgical removal (adenoidectomy) if breathing or sleep is significantly affected.

Air Quality and Baby Health

Babies and young children are more vulnerable to air pollution than adults because they breathe faster, their lungs are still developing, and they spend more time close to the ground where some pollutants concentrate. The EPA recommends keeping babies indoors when the Air Quality Index (AQI) exceeds 100 (orange level). During wildfire smoke events, keep windows closed, use air purifiers with HEPA filters, and monitor your child for coughing, wheezing, or difficulty breathing. Long-term exposure to air pollution can affect lung development.

Altitude Sickness in Babies

Babies and toddlers can experience altitude sickness when traveling above 5,000-8,000 feet (1,500-2,500 meters). Symptoms are harder to recognize in infants because they cannot describe how they feel. Watch for unusual fussiness, poor feeding, disrupted sleep, vomiting, and fast breathing. Gradual ascent is the best prevention. Most pediatricians recommend avoiding sleeping at very high altitudes (above 8,000 feet) with infants when possible, and descending immediately if symptoms appear.

Amblyopia (Lazy Eye) Treatment Timing

Amblyopia (lazy eye) is the most common cause of vision loss in children, affecting 2-3% of the population. It occurs when one eye develops weaker vision because the brain favors the other eye. Early detection and treatment are critical because the visual system is most responsive to treatment during early childhood. Treatment is most effective when started before age 7, though improvement is possible at older ages. Treatment options include patching the stronger eye, atropine eye drops, glasses, or a combination.